Form 8-K - Current report:
SEC Accession No. 0001437749-24-033147
Filing Date
2024-11-04
Accepted
2024-11-04 16:32:45
Documents
15
Period of Report
2024-11-01
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K krbp20241104_8k.htm   iXBRL 8-K 27306
2 EXHIBIT 10.1 ex_742377.htm EX-10.1 57054
  Complete submission text file 0001437749-24-033147.txt   233215

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA krbp-20241101.xsd EX-101.SCH 3409
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE krbp-20241101_def.xml EX-101.DEF 11819
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE krbp-20241101_lab.xml EX-101.LAB 15884
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE krbp-20241101_pre.xml EX-101.PRE 12034
17 EXTRACTED XBRL INSTANCE DOCUMENT krbp20241104_8k_htm.xml XML 2932
Mailing Address 7707 FANNIN ST. SUITE 140 HOUSTON TX 77054
Business Address 7707 FANNIN ST. SUITE 140 HOUSTON TX 77054 832-968-4888
Kiromic Biopharma, Inc. (Filer) CIK: 0001792581 (see all company filings)

EIN.: 464762913 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39619 | Film No.: 241424105
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)